Sei Investments CO Harrow Health, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Harrow Health, Inc. stock. As of the latest transaction made, Sei Investments CO holds 15,679 shares of HROW stock, worth $611,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,679

Holding current value

$611,637

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $326,907 - $728,603	15,679 New	15,679 $704,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $310,099 - $480,832	22,406 New	22,406 $474,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

Opaleye Management Inc. Boston, MA

3.99M
Shares

$156 Million
32.75% of portfolio
Private Capital Management, LLC Naples, FL

2.16M
Shares

$84.4 Million
11.41% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$83.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$72.8 Million
0.0% of portfolio
State Street Corp Boston, MA

731K
Shares

$28.5 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account